WallStreetZenWallStreetZen

NASDAQ: DTIL
Precision Biosciences Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DTIL past revenue growth

How has DTIL's revenue growth performed historically?
Company
94.15%
Industry
148.4%
Market
16.96%
DTIL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
DTIL's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
DTIL's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

DTIL earnings and revenue history

Current Revenue
$48.7M
Current Earnings
-$61.3M
Current Profit Margin
-125.8%

DTIL Return on Equity

Current Company
-200.8%
Current Industry
-63.5%
Current Market
188%
DTIL's Return on Equity (-200.8%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DTIL announces earnings.

DTIL Return on Assets

Current Company
-34.5%
Current Industry
2.9%
DTIL is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DTIL Return on Capital Employed

Current Company
-53.82%
Current Industry
19.5%
DTIL has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DTIL vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DTIL$48.73M-$50.83M-$61.32M+34.96%N/A
CSBR$49.22M-$7.67M-$9.73M+15.19%N/A
PASG$0.00-$98.34M-$102.06MN/AN/A
CUE$5.49M-$46.05M-$50.73M+36.88%N/A
LABP$0.00-$21.94M-$21.94MN/AN/A
View Top Biotech Stocks

DTIL earnings dates

Next earnings date
May 7, 2024

Precision Biosciences Earnings & Revenue FAQ

What were DTIL's earnings last quarter?

On Invalid Date, Precision Biosciences (NASDAQ: DTIL) reported Q4 2023 earnings per share (EPS) of -$3.96, up 42.61% year over year. Total Precision Biosciences earnings for the quarter were -$16.29 million. In the same quarter last year, Precision Biosciences's earnings per share (EPS) was -$6.90.

If you're new to stock investing, here's how to buy Precision Biosciences stock.

What was DTIL's earnings growth in the past year?

As of Q2 2024, Precision Biosciences's earnings has grown year over year. Precision Biosciences's earnings in the past year totalled -$61.32 million.

What is DTIL's earnings date?

Precision Biosciences's earnings date is Invalid Date. Add DTIL to your watchlist to be reminded of DTIL's next earnings announcement.

What was DTIL's revenue last quarter?

On Invalid Date, Precision Biosciences (NASDAQ: DTIL) reported Q4 2023 revenue of $7.04 million up 33.59% year over year. In the same quarter last year, Precision Biosciences's revenue was $10.60 million.

What was DTIL's revenue growth in the past year?

As of Q2 2024, Precision Biosciences's revenue has grown 94.15% year over year. This is 54.26 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Precision Biosciences's revenue in the past year totalled $48.73 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.